Pandemic delays development of innovative cell and gene therapies – from McKinnsey

$0.00

A survey of disruptions in R&D activities revealed many problems: 45 percent of respondents expected delays of three to six months on average for development programs.

Category:

Description

A survey of disruptions in R&D activities revealed many problems: 45 percent of respondents expected delays of three to six months on average for development programs.

%d bloggers like this: